BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30078466)

  • 1. A Comprehensive In Vivo and In Vitro Assessment of the Drug Interaction Potential of Red Ginseng.
    Seong SJ; Kang WY; Heo JK; Jo J; Choi WG; Liu KH; Lee S; Choi MK; Han YH; Lee HS; Ohk B; Lee HW; Song IS; Yoon YR
    Clin Ther; 2018 Aug; 40(8):1322-1337. PubMed ID: 30078466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants.
    Bansal S; Zamarripa CA; Spindle TR; Weerts EM; Thummel KE; Vandrey R; Paine MF; Unadkat JD
    Clin Pharmacol Ther; 2023 Sep; 114(3):693-703. PubMed ID: 37313955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Upadacitinib Coadministration on the Pharmacokinetics of Sensitive Cytochrome P450 Probe Substrates: A Study With the Modified Cooperstown 5+1 Cocktail.
    Mohamed MF; Feng T; Enejosa JV; Fisniku O; Othman AA
    J Clin Pharmacol; 2020 Jan; 60(1):86-95. PubMed ID: 31378969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vercirnon on the activity of CYP3A4, CYP2C19 and CYP2C8 enzymes and BCRP and OATP1B1 transporters using probe substrates.
    Haberer LJ; McSherry I; Cargill A; McCarthy L
    Eur J Clin Pharmacol; 2014 Jan; 70(1):37-45. PubMed ID: 24100471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Drug-Drug Interaction Potential of Enarodustat (JTZ-951) Using a Cytochrome P450 Probe Cocktail.
    Pai SM; Yamada H; Murata H
    Clin Pharmacol Drug Dev; 2023 Jul; 12(7):667-682. PubMed ID: 37269147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Viloxazine Extended-Release Capsules (Qelbree
    Wang Z; Liranso T; Maldonado-Cruz Z; Kosheleff AR; Nasser A
    Clin Drug Investig; 2024 May; 44(5):303-317. PubMed ID: 38598106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers.
    Rohr BS; Krohmer E; Foerster KI; Burhenne J; Schulz M; Blank A; Mikus G; Haefeli WE
    Clin Pharmacokinet; 2024 Apr; 63(4):469-481. PubMed ID: 38393578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the Effects of Abrocitinib on the Pharmacokinetics of Probe Substrates of Cytochrome P450 1A2, 2B6 and 2C19 Enzymes and Hormonal Oral Contraceptives in Healthy Individuals.
    Wang X; Dowty ME; Tripathy S; Le VH; Huh Y; Curto M; Winton JA; O'Gorman MT; Chan G; Malhotra BK
    Eur J Drug Metab Pharmacokinet; 2024 May; 49(3):367-381. PubMed ID: 38554232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Development and Validation of a Novel "Dual Cocktail" Probe for Cytochrome P450s and Transporter Functions to Evaluate Pharmacokinetic Drug-Drug and Herb-Drug Interactions.
    Kwon M; Jeon JH; Choi MK; Song IS
    Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 33007943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic.
    Yadav AS; Stevison F; Kosaka M; Wong S; Kenny JR; Amory JK; Isoherranen N
    Drug Metab Dispos; 2022 Jul; 50(7):1042-1052. PubMed ID: 35545255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours.
    Tachibana M; Papadopoulos KP; Strickler JH; Puzanov I; Gajee R; Wang Y; Zahir H
    Br J Clin Pharmacol; 2018 Jan; 84(1):112-121. PubMed ID: 28865153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herb-Drug Interaction of Red Ginseng Extract and Ginsenoside Rc with Valsartan in Rats.
    Jeon JH; Lee S; Lee W; Jin S; Kwon M; Shin CH; Choi MK; Song IS
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32023909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro.
    Stage TB; Graff M; Wong S; Rasmussen LL; Nielsen F; Pottegård A; Brøsen K; Kroetz DL; Khojasteh SC; Damkier P
    Br J Clin Pharmacol; 2018 Mar; 84(3):510-519. PubMed ID: 29105855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the drug-drug interaction and incompatibility mechanism between Aconitum carmichaelii Debx and Pinellia ternata (Thunb.) Breit.
    Ge M; Ouyang H; Shang Y; Biu AM; Wu X; Li C; Zuo F; Zhu Y; Xue Z; Hao J; He J
    J Ethnopharmacol; 2024 Aug; 330():118212. PubMed ID: 38636577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the potential impact on pharmacokinetics of various cytochrome P450 substrates of increasing IL-6 levels following administration of the T-cell bispecific engager glofitamab.
    Djebli N; Parrott N; Jaminion F; O'Jeanson A; Guerini E; Carlile D
    CPT Pharmacometrics Syst Pharmacol; 2024 Mar; 13(3):396-409. PubMed ID: 38044486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Characterization of Drug Metabolism and the Influence of the Intestinal Microbiome: A Pharmacokinetic, Microbiome, and Untargeted Metabolomics Study.
    Jarmusch AK; Vrbanac A; Momper JD; Ma JD; Alhaja M; Liyanage M; Knight R; Dorrestein PC; Tsunoda SM
    Clin Transl Sci; 2020 Sep; 13(5):972-984. PubMed ID: 32216086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Clinical Drug-Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach.
    de Vries M; Bonsmann S; Pausch J; Sumner M; Birkmann A; Zimmermann H; Kropeit D
    Clin Pharmacol Drug Dev; 2024 May; ():. PubMed ID: 38752475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Use of In Vitro and In Vivo Information for Comprehensive Prediction of Drug Interactions Due to Inhibition of Multiple CYP Isoenzymes.
    Hozuki S; Yoshioka H; Asano S; Nakamura M; Koh S; Shibata Y; Tamemoto Y; Sato H; Hisaka A
    Clin Pharmacokinet; 2023 Jun; 62(6):849-860. PubMed ID: 37076696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a bupropion, dextromethorphan, and omeprazole cocktail for simultaneous phenotyping of cytochrome P450 2B11, 2D15, and 3A12 activities in dogs.
    Martinez SE; Jimenez TEP; Court MH
    Am J Vet Res; 2024 May; ():1-10. PubMed ID: 38718826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Microdosing for In vivo Phenotyping of Cytochrome P450 Enzymes: Where Do We Stand? A Narrative Review.
    van der Heijden LT; Opdam FL; Beijnen JH; Huitema ADR
    Eur J Drug Metab Pharmacokinet; 2024 Apr; ():. PubMed ID: 38689161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.